About Us

Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

A Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Social Media

Bluesky • Facebook • Instagram • LinkedIn • YouTube

Meet the Laser Focus World Team

Editorial

Sales

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

5 Must-Read Analyst Questions From Progyny’s Q2 Earnings Call

By: StockStory

PGNY Cover Image

Progyny’s second quarter results demonstrated stable growth, with management highlighting a return to more typical seasonal patterns in member activity and engagement across its employer client base. The company attributed revenue gains to increased client adoption and a wider range of covered lives, as well as the successful integration of recent acquisitions. CEO Pete Anevski emphasized that new client wins spanned diverse industries, reflecting broad appeal for Progyny’s fertility and family-building solutions. The company also pointed to strong progress in expanding its product portfolio, supporting both member outcomes and cost control.

Is now the time to buy PGNY? Find out in our full research report (it’s free).

Progyny (PGNY) Q2 CY2025 Highlights:

  • Revenue: $332.9 million vs analyst estimates of $320.4 million (9.5% year-on-year growth, 3.9% beat)
  • Adjusted EPS: $0.48 vs analyst estimates of $0.43 (12.1% beat)
  • Adjusted EBITDA: $57.95 million vs analyst estimates of $52.95 million (17.4% margin, 9.4% beat)
  • The company lifted its revenue guidance for the full year to $1.25 billion at the midpoint from $1.21 billion, a 3.5% increase
  • Management raised its full-year Adjusted EPS guidance to $1.74 at the midpoint, a 9.4% increase
  • EBITDA guidance for the full year is $210 million at the midpoint, above analyst estimates of $200.2 million
  • Operating Margin: 7.3%, in line with the same quarter last year
  • Sales Volumes rose 8.8% year on year (5.4% in the same quarter last year)
  • Market Capitalization: $1.98 billion

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From Progyny’s Q2 Earnings Call

  • Daniel Christopher Clark (Leerink Partners) asked if early sales commitments were being measured on a gross or net basis, to which CEO Pete Anevski clarified that comparisons exclude the large former client, focusing on organic growth.
  • Jailendra P. Singh (Truist) inquired whether smaller employers are increasingly adopting multiple services and if larger employers are slower to decide. Anevski explained that pipeline timing varied by employer size, but both small and large wins were materializing.
  • Unidentified Analyst (Bank of America) questioned how average revenue per ART cycle would trend in the back half of the year. CFO Mark Livingston noted that early-year revenue per cycle is inflated by initial consults and that full-year averages should normalize.
  • Sarah Elizabeth James (Cantor) asked if the higher revenue per new client was due to broader product uptake or industry utilization differences. Anevski confirmed it was driven by higher-utilizing industries rather than broader product adoption.
  • David Michael Larsen (BTIG) probed on changes in service mix, such as egg freezing versus transfers. Anevski stated that mix had returned to normal seasonal patterns, with no significant shifts impacting results.

Catalysts in Upcoming Quarters

Looking ahead, the StockStory team will be monitoring (1) the pace of new client additions and the demographic mix of covered lives during the remainder of the selling season, (2) progress on the rollout and adoption of new women’s health services, and (3) the impact of operational investments on gross margins as the company prepares for 2026 launches. The evolution of strategic partnerships, such as with Amazon, will also be a key area of focus.

Progyny currently trades at $22.75, down from $23.02 just before the earnings. Is the company at an inflection point that warrants a buy or sell? The answer lies in our full research report (it’s free).

The Best Stocks for High-Quality Investors

Trump’s April 2025 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines.

Take advantage of the rebound by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

More News

View More
General Dynamics Hits New Highs: Why It Might Keep Climbing
Via MarketBeat
Tickers GD
Nike’s Turnaround: If the Shoe Fits, Buy It!
Via MarketBeat
Tickers NKE
NVIDIA Breaks Out to New Highs: What Comes Next?
Via MarketBeat
Topics Economy Stocks World Trade
Tickers CRWV META NVDA
Microsoft Stock Hits Stride in 2025—How Much More Can It Run?
Via MarketBeat
Topics Artificial Intelligence Retirement
Tickers MSFT
How Berkshire's OxyChem Buy Cements Its Long-Term Strength
Via MarketBeat
Tickers BRK BRK-A BRK-B OXY
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.